Onshoring U.S. Pharmaceutical Manufacturing: COVID-19, Congress and Puerto Rico Pharma Hub
Onshoring U.S. Pharmaceutical Manufacturing: COVID-19, Congress and Puerto Rico Pharma Hub Ideas for returning pharmaceutical manufacturing to the U.S. With its significant investment in biomedical research, the United States is one of the foremost leaders worldwide...
How Pharma and Life Science Distributors Avoid Supply Chain Disruption During COVID-19 Outbreak
How Pharma and Life Science Distributors Avoid Supply Chain Disruption During COVID-19 Outbreak Life science supply chain disruptions avoided with advance planning during COVID-19 outbreak First, consumers and professionals in the pharmaceutical industry feared that...
Coronavirus May Disrupt U.S. Pharma/Life Sciences Supply Chain
Coronavirus May Disrupt U.S. Pharma/Life Sciences Supply Chain How the coronavirus outbreak may impact U.S. prescription drugs, medical devices, PPE and nutritional supplements As of February 13th, 60 million people in China have been quarantined to prevent the spread...
How New 3PL Pharma Services and Title Models Can Benefit Drug Manufacturers
How New 3PL Pharma Services and Title Models Can Benefit Drug Manufacturers How Can Use of 3PL Pharma Services Benefit Drug Manufacturers? The highly complex pharma life sciences industry seems to be constantly changing. To keep up with the pace of change, ensure...